Related Experiment Video
Updated: Mar 15, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
[The use of Pantogam syrup in treating small children's breath holding spells]
A V Polskaya1, L S Chutko1, E V Jakovenko1
1Institute of Human Brain, Russian Academy of Sciences, St. Petersburg, Russia.
Insights
Pantogam syrup (hopantenic acid) effectively treats breath-holding spells (BHS) in children. This neuroprotective therapy significantly improved clinical symptoms and reduced anxiety compared to psychological methods alone.
Area of Science:
- Pediatric Neurology
- Pharmacology
Background:
- Breath-holding spells (BHS) are common in young children.
- Anxiety and neurophysiological abnormalities are associated with BHS.
Purpose of the Study:
- To evaluate the efficacy of pantogam syrup 10% (hopantenic acid) for treating BHS in children.
- To assess the impact of pantogam on clinical manifestations, anxiety, and neurophysiological indicators.
Main Methods:
- A study involving 60 children aged 2-4 years with BHS.
- Division into two groups: a main group receiving pantogam syrup and a control group receiving psychological methods.
- Evaluation included clinical assessment, anxiety level measurement, and long-term video-EEG monitoring.
Main Results:
- Clinical improvement observed in 73.3% of children treated with pantogam syrup, versus 16.7% in the control group.
- Significant reduction in anxiety levels following neuroprotective therapy.
- EEG analysis showed decreased slow rhythms and improved brain functional maturity in the pantogam group.
Conclusions:
- Pantogam syrup demonstrates high efficacy in treating pediatric BHS.
- Hopantenic acid offers a beneficial neuroprotective effect.
- Pantogam syrup is a promising therapeutic option for managing BHS in children.
Aim:
To study the efficacy of pantogam syrup 10% (hopantenic acid) in the treatment of breath-holding spells (BHS).
Material And Methods:
Sixty children, aged from 2 to 4 years, with BHS were studied. The evaluation of clinical manifestations and anxiety level was performed. Results of neurophysiological examination (long-term video-EEG-monitoring) were analyzed. Children were divided into 2 groups: main, in which the patients received pantogam syrup, and control group, in which only psychological methods were used.
Results And Conclusion:
The results of the clinical and neurophysiological studies performed after the treatment, showed the clinical improvement in 73.3% of patients of the main group compared with similar data from the children in the control group (16.7%). The anxiety level significantly decreased after the neuroprotective therapy. A comparative analysis of electroencephalographic indicators demonstrated a significant (р<0.05) reduction in the power range of slow rhythms and manifestations of functional immaturity of the brain in patients of the main group. These results give evidence for the high efficacy of pantogam syrup in the treatment of children with BHS.
More Related Videos
Related Concept Videos
Drug Delivery: Enteral Route
Cardiopulmonary Resuscitation II: ACLS Airway Management
Breathing
Pharmaceutical Poisoning: Treatment Strategies
Prevention of Further Absorption of Poison
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

